LRRK2 is reduced in Parkinson’s disease gut

被引:0
|
作者
Adrien de Guilhem de Lataillade
Jérémy Verchere
Thibauld Oullier
Alice Prigent
Tony Durand
Carolina Pellegrini
Michel Neunlist
Thierry Baron
Malvyne Rolli-Derkinderen
Pascal Derkinderen
机构
[1] Université de Nantes,Department of Neurology
[2] Inserm,French Agency for Food, Environmental, and Occupational Health and Safety (ANSES)
[3] TENS,Department of Pharmacy
[4] The Enteric Nervous System in Gut and Brain Diseases,undefined
[5] IMAD,undefined
[6] CHU Nantes,undefined
[7] Inserm U1235 Nantes,undefined
[8] University of Lyon,undefined
[9] University of Pisa,undefined
来源
Acta Neuropathologica | 2021年 / 142卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
下载
收藏
页码:601 / 603
页数:2
相关论文
共 50 条
  • [21] LRRK2 and the Endolysosomal System in Parkinson's Disease
    Erb, Madalynn L.
    Moore, Darren J.
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (04) : 1271 - 1291
  • [22] LRRK2 in Parkinson's disease: biochemical functions
    Anand, Vasanti S.
    Braithwaite, Steven P.
    FEBS JOURNAL, 2009, 276 (22) : 6428 - 6435
  • [23] Lrrk2 pathogenic substitutions in Parkinson's disease
    Ignacio F. Mata
    Jennifer M. Kachergus
    Julie P. Taylor
    Sarah Lincoln
    Jan Aasly
    Timothy Lynch
    Mary M. Hulihan
    Stephanie A. Cobb
    Ruey-Meei Wu
    Chin-Song Lu
    Carlos Lahoz
    Zbigniew K. Wszolek
    Matthew J. Farrer
    Neurogenetics, 2005, 6 : 171 - 177
  • [24] LRRK2 as a therapeutic target in Parkinson's disease
    Tan, E. K.
    Schapira, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (04) : 545 - 546
  • [25] Pathological Functions of LRRK2 in Parkinson's Disease
    Jeong, Ga Ram
    Lee, Byoung Dae
    CELLS, 2020, 9 (12) : 1 - 19
  • [26] LRRK2 activation in idiopathic Parkinson's disease
    Di Maio, Roberto
    Hoffman, Eric K.
    Rocha, Emily M.
    Keeney, Matthew T.
    Sanders, Laurie H.
    De Miranda, Briana R.
    Zharikov, Alevtina
    Van Laar, Amber
    Stepan, Antonia F.
    Lanz, Thomas A.
    Kofler, Julia K.
    Burton, Edward A.
    Alessi, Dario R.
    Hastings, Teresa G.
    Greenamyre, J. Timothy
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (451)
  • [27] LRRK2 mutations in Parkinson disease
    Farrer, M
    Stone, J
    Mata, IF
    Lincoln, S
    Kachergus, J
    Hulihan, M
    Strain, KJ
    Maraganore, DM
    NEUROLOGY, 2005, 65 (05) : 738 - 740
  • [28] The structure of LRRK2 and the conformational changes that are associated with LRRK2 activation and Parkinson's disease pathogenesis
    Weng, Jui-Hung
    Auto, Philip
    Lu, Tsan-Wen
    Taylor, Susan
    FASEB JOURNAL, 2020, 34
  • [29] The Structure of LRRK2 and the Conformational Changes that are Associated with LRRK2 Activation and Parkinson's Disease Pathogenesis
    Weng, Jui-Hung
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 41A - 41A
  • [30] Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2
    Belluzzi, Elisa
    Greggio, Elisa
    Piccoli, Giovanni
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1111 - 1116